相关实验视频
Updated: Jun 15, 2025

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
儿科慢性炎症性脱线性多神经病症:诊断和治疗策略的挑战
Issa Alawneh1, Asmaa Alenizi1, Freddy Paiz1
1Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
慢性炎症性脱髓化多神经病 (CIDP) 在儿童中提出了独特的诊断挑战,通常与遗传性神经病 (如Charcot-Marie-Tooth病) 重叠. 本综述探讨了这些诊断障碍,并讨论了儿科CIDP的当前和新型治疗策略.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 慢性炎症性脱髓化多神经病 (CIDP) 是一种罕见的自身免疫性疾病,影响儿童和成人.
- CIDP通常表现为至少四周的渐进性虚弱和感官症状.
- 儿科CIDP可以呈现出独特的特征,需要仔细区分与遗传性神经病变.
研究的目的:
- 审查儿童群体中CIDP的诊断挑战.
- 讨论儿童中CIDP和脱髓化Charcot-Marie-Tooth病 (dCMT) 之间的差异诊断.
- 检查当前和新兴的治疗方案,为儿科CIDP.
主要方法:
- 文献综述侧重于儿科CIDP的诊断标准和治疗干预措施.
- 对临床和电诊断特征的分析,使CIDP与dCMT有所区别.
- 评估已建立的治疗方法 (IVIG,皮质类固醇,PLEX) 和新的治疗方法.
主要成果:
- CIDP和dCMT之间的诊断重叠是一个重大挑战,有时需要进行遗传测试.
- 脑脊液 (CSF) 分析和电诊断可能并不总是区分CIDP和dCMT.
- 对于一些儿科患者来说,标准的CIDP疗法可能不足,这凸显了对替代治疗的需求.
结论:
- 儿童CIDP的准确诊断是复杂的,因为它与遗传性神经病变重叠.
- 在没有反应的情况下,应该考虑早期进行基因检测.
- 开发新型疗法对于管理耐药儿科CIDP和减轻长期标准治疗的不良影响至关重要.
更多相关视频
04:55A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Parkinson's Disease: Overview